HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 140 | 163 | 85.9% | |
| HF004 | 2020 | 141 | 163 | 86.5% | |
| HF006 | 2021 | 182 | 195 | 93.3% | |
| HF006 | 2022 | 180 | 189 | 95.2% | |
| HF006 | 2023 | 172 | 184 | 93.5% |
